Literature DB >> 24232951

Sickle cell retinopathy: diagnosis and treatment.

Maria Teresa Brizzi Chizzotti Bonanomi, Marcelo Mendes Lavezzo.   

Abstract

Hemoglobinopathies are a group of inherited disorders characterized by quantitative or qualitative malformations of hemoglobin (Hb). Some of these diseases present vaso-occlusive phenomena that are responsible for high morbidity in clinical and/or ophthalmologic terms. Diagnosis of hemoglobinopathies is performed exclusively through hemoglobin electrophoresis. From the ophthalmologic perspective, the most important representative of this group of diseases is sickle cell retinopathy, which presents a wide spectrum of fundus manifestations and may even lead to irreversible vision loss if not properly diagnosed and treated. The aim of this review is to present the classification of sickle cell retinopathy and to describe current management and future perspectives for its treatment, taking into consideration the clinical management of these patients.

Entities:  

Mesh:

Year:  2013        PMID: 24232951     DOI: 10.1590/s0004-27492013000500016

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  10 in total

1.  Oral Monomethyl Fumarate Therapy Ameliorates Retinopathy in a Humanized Mouse Model of Sickle Cell Disease.

Authors:  Wanwisa Promsote; Folami Lamoke Powell; Satyam Veean; Menaka Thounaojam; Shanu Markand; Alan Saul; Diana Gutsaeva; Manuela Bartoli; Sylvia B Smith; Vadivel Ganapathy; Pamela M Martin
Journal:  Antioxid Redox Signal       Date:  2016-08-22       Impact factor: 8.401

2.  Central retinal artery occlusion and traumatic optic neuropathy following blunt ocular trauma.

Authors:  Jasmin Zvorničanin; Ferenc Kuhn; Meliha Halilbašić; Zlatko Mušanović
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

3.  Computer-aided classification of sickle cell retinopathy using quantitative features in optical coherence tomography angiography.

Authors:  Minhaj Alam; Damber Thapa; Jennifer I Lim; Dingcai Cao; Xincheng Yao
Journal:  Biomed Opt Express       Date:  2017-08-25       Impact factor: 3.732

4.  Ocular manifestations in egyptian children and young adults with sickle cell disease.

Authors:  Mona Kamal El-Ghamrawy; Hanan F El Behairy; Amal El Menshawy; Seham A Awad; Ahmed Ismail; Mohamed Salah Gabal
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-23       Impact factor: 0.900

Review 5.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

6.  Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report.

Authors:  Panagiotis G Mitropoulos; Irini P Chatziralli; Efstratios A Parikakis; Vasileios G Peponis; Georgios A Amariotakis; Marilita M Moschos
Journal:  Case Rep Ophthalmol Med       Date:  2014-11-23

7.  Chronic Disease Management in Sickle Cell Trait Patients in the Primary Care Setting: A Case Report.

Authors:  Rachel N Fields; Suzanne Minor
Journal:  Cureus       Date:  2020-10-30

8.  Sickle Cell Trait Presenting as Unilateral Proliferative Retinopathy and Macular Thinning in a Pregnant Woman.

Authors:  Sepideh Ghods; Elias Khalili Pour; Hooshang Faghihi; Golnaz Gharehbaghi; Ahmad Mirshahi; Fariba Ghassemi; Bahman Inanloo; Hamid Riazi-Esfahani
Journal:  Case Rep Ophthalmol Med       Date:  2021-12-11

9.  Unusual presentation of ocular trauma in sickle cell trait.

Authors:  Nidhi Pandey
Journal:  Indian J Ophthalmol       Date:  2015-09       Impact factor: 1.848

10.  Retinopathy in Egyptian patients with sickle cell disease: A cross-sectional study.

Authors:  Tamer Hassan; Mohamed Badr; Diana Hanna; Mohamed Arafa; Ahmed Elhewala; Sherief Dabour; Saad Shehata; Doaa Abdel Rahman
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.